Benefits: 
 
-Improves tendon, bone, and ligament healing by boosting the levels of Epidermal Growth Factor (EGF), Fibroblast Growth Factor (FGF), and Vascular Endothelial Growth Factor (VEGF)
-Accelerates wound healing 
-Accelerates healing of soft tissue injuries 
-Improves bone and joint health 
-Improves digestive health 
-Normalizes blood pressure 
-Corrects potassium imbalance 
-Corrects calcium imbalance 
-Corrects magnesium imbalance 
-Strengthens the immune system 
-Protects against NSAID toxicity and related adverse side effects 
-Reverses alcohol intoxication 
-Improves mood and behavior 
-Improves cognitive health 
-Exerts anti-cancer properties 
 
BPC 157 offers a wide range of therapeutic benefits. It is a synthetic peptide derived from a protein found in the stomach. It’s often referred to as a “stable gastric pentadecapeptide” due to its stability in human gastric juice. So it is stable as either an oral capsule or as injectable locally-applied peptide. We opt for the latter as it demonstrates greater efficacy in acute injury repair. BPC-157 has shown potential benefits in laboratory and preclinical studies, with no identifiable side effects.
 
BPC-157 works by stimulating the formation of new blood vessels. This process is called angiogenesis and is important in promoting healing and faster cell regeneration. Angiogenesis is an integral part of the wound-healing process and the organization of the blood vessel network.
 
Soft tissue injuries refer to damage to the muscles, tendons, and ligaments. They can be partial or complete tears and may require surgical repair. Interestingly, BPC-157 has shown promise in preclinical studies for promoting the healing of tendon-to-bone damage, potentially accelerating the recovery process in musculoskeletal injuries:
 
In rats with Achilles tendon injury, BPC-157 significantly improved healing, thereby eliminating the need for surgical repair. BPC-157 promoted tendon outgrowth, cell survival, and cell migration in the injured soft tissues of rats, resulting in improved soft tissue healing. In rats with muscle crush injury, BPC-157 induced faster muscle healing and full function restoration. In rat tendon cells, pretreatment with BPC-157 showed outcomes close to the noninjured ligament as evidenced by faster granulation tissue formation, better organization of collagen, and reduced inflammatory cells, suggesting improved ligament healing. In rats with injury to the sciatic nerve (nerve in the spinal cord), BPC-157 administration reversed the death of nerve cells and cyst formation and protected against damage to nerve structures.
 
BPC-157 plays a crucial role in maintaining bone and joint health. Studies show that BPC-157 exerts this beneficial effect through the following: In rabbits, BPC-157 significantly improved the healing of segmental bone defects by increasing bone density. In rats, BPC-157 administration counteracted knee osteoarthritis and reduced cartilage lesions and joint pain, resulting in improved leg length and mobility.
 
Current research suggests that BPC-157 may also help improve digestive function and overall digestive health. In rats, BPC-157 prevented the development of stomach ulcers by protecting the layers of the stomach against the direct cellular damaging effect of ethanol. BPC-157 fully interacted with the dopamine system (group of nerve cells in the midbrain) of rats to prevent mechanisms involved in ulcer formation. Continuous administration of BPC-157 in rats with chronic gastric ulcers accelerated the rebuilding of stomach tissues and the formation of granulation tissues. BPC-157 administration in rats was able to treat stomach ulcer by reducing gastrointestinal tract lesions.
In rats with inflammatory bowel disease, BPC-157 administration resulted in faster healing of the damaged colon and improved tendon, bone, and ligament healing by boosting the levels of Epidermal Growth Factor (EGF), Fibroblast Growth Factor (FGF), and Vascular Endothelial Growth Factor (VEGF). [41-45]